Vector BioPharma

company

About

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$30M
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2021
Number Of Employee
11 - 50
Operating Status
Active

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Vector BioPharma has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Aug 10, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 10, 2022 Series A $30M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Vector BioPharma is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A